Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide for Gastric Emptying in Mechanically Ventilated Patients
NCT05641051Phase 4Completed
- Sponsor
- Tanta University
- Start
- Dec 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metoclopramide in Motility Disorders (2 arms), sponsored by Tanta University. Primary endpoint: Assessment of the risk of aspiration. Started Dec 2022; status: completed.
02
Drugs
metoclopramide
03
Conditions
Motility Disorders
Beyond the preview
Go deeper on NCT05641051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641051.